Human Genetics

, Volume 125, Issue 2, pp 217–229 | Cite as

Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis

  • David R. Crosslin
  • Svati H. Shah
  • Sarah C. Nelson
  • Carol S. Haynes
  • Jessica J. Connelly
  • Shera Gadson
  • Pascal J. Goldschmidt-Clermont
  • Jeffery M. Vance
  • Jason Rose
  • Chris B. Granger
  • David Seo
  • Simon G. Gregory
  • William E. Kraus
  • Elizabeth R. Hauser
Original Investigation

Abstract

Leukotrienes are arachidonic acid derivatives long known for their inflammatory properties and their involvement with a number of human diseases, most particularly asthma. Recently, leukotriene-based inflammation has also been shown to play an important role in atherosclerosis: ALOX5AP and LTA4H, both genes in the leukotriene biosynthesis pathway, have individually been shown to be associated with various cardiovascular disease (CVD) phenotypes. To assess the role of the leukotriene pathway in CVD pathogenesis, we performed genetic association studies of ALOX5AP and LTA4H in a family based study of early onset coronary artery disease (EOCAD) (GENECARD, 1,101 families) and in a non-familial dataset of EOCAD (CATHGEN, 656 cases and 405 controls). We found weak to moderate association between single nucleotide polymorphisms (SNPs) in ALOX5AP and LTA4H with EOCAD. The previously reported four-SNP haplotype (HapA) in ALOX5AP showed association with EOCAD in CATHGEN (P = 0.02), while controlling for age, race and CVD risk factors. HapK, the previously reported ten-SNP haplotype in LTA4H was associated with EOCAD in CATHGEN (P = 0.04). Another previously reported four-SNP haplotype in ALOX5AP (HapB) was not significant in our sample (P = 0.39). The overall lack of (or weak) association of single SNPs as compared with the haplotype results demonstrates the need for analyzing multiple SNPs within each gene in such studies. Interestingly, we detected an association of SNPs in ALOX5 (P < 0.05), the target of ALOX5AP, with CVD. Using a pathway-based approach, we also detected statistical evidence for interactions among ALOX5, ALOX5AP and LTA4H using RNA expression data from a collection of freshly harvested human aortas with varying degrees of atherosclerosis. The GENECARD families did not demonstrate evidence for linkage or association with ALOX5, ALOX5AP or LTA4H. Our results support a modest role for the leukotriene pathway in atherosclerosis pathogenesis, reveal important genomic interactions within the pathway, and suggest the importance of using pathway-based modeling for evaluating the genomics of atherosclerosis susceptibility.

Supplementary material

439_2008_619_MOESM1_ESM.pdf (225 kb)
Electronic supplementary material (PDF 225 kb)

References

  1. Abecasis GR, Cherny SS, Cookson WO, Cardon LR (2002) Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 30:97–101PubMedCrossRefGoogle Scholar
  2. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263–265PubMedCrossRefGoogle Scholar
  3. Chung RH, Hauser ER, Martin ER (2006) The APL test: extension to general nuclear families and haplotypes and examination of its robustness. Hum Hered 61:189–199PubMedCrossRefGoogle Scholar
  4. Cipollone F, Mezzetti A, Fazia ML, Cuccurullo C, Iezzi A, Ucchino S, Spigonardo F, Bucci M, Cuccurullo F, Prescott SM, Stafforini DM (2005) Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler Thromb Vasc Biol 25:1665–1670PubMedCrossRefGoogle Scholar
  5. Cornhill JF, Barrett WA, Herderick EE, Mahley RW, Fry DL (1985) Topographic study of sudanophilic lesions in cholesterol-fed minipigs by image analysis. Arteriosclerosis 5:415–426PubMedGoogle Scholar
  6. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, Mar R, Lusis AJ, Mehrabian M (2004) Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N Engl J Med 350:29–37PubMedCrossRefGoogle Scholar
  7. Funk CD (2005) Leukotriene modifiers as potential therapeutics for cardiovascular disease. Nat Rev Drug Discov 4:664–672PubMedCrossRefGoogle Scholar
  8. Hauser ER, Crossman DC, Granger CB, Haines JL, Jones CJ, Mooser V, McAdam B, Winkelmann BR, Wiseman AH, Muhlestein JB, Bartel AG, Dennis CA, Dowdy E, Estabrooks S, Eggleston K, Francis S, Roche K, Clevenger PW, Huang L, Pedersen B, Shah S, Schmidt S, Haynes C, West S, Asper D, Booze M, Sharma S, Sundseth S, Middleton L, Roses AD, Hauser MA, Vance JM, Pericak-Vance MA, Kraus WE (2004) A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD study. Am J Hum Genet 75:436–447PubMedCrossRefGoogle Scholar
  9. Hauser ER, Mooser V, Crossman DC, Haines JL, Jones CH, Winkelmann BR, Schmidt S, Scott WK, Roses AD, Pericak-Vance MA, Granger CB, Kraus WE (2003) Design of the Genetics of Early Onset Cardiovascular Disease (GENECARD) study. Am Heart J 145:602–613PubMedCrossRefGoogle Scholar
  10. Helgadottir A, Gretarsdottir S, St Clair D, Manolescu A, Cheung J, Thorleifsson G, Pasdar A, Grant SF, Whalley LJ, Hakonarson H, Thorsteinsdottir U, Kong A, Gulcher J, Stefansson K, MacLeod MJ (2005a) Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 76:505–509PubMedCrossRefGoogle Scholar
  11. Helgadottir A, Manolescu A, Helgason A, Thorleifsson G, Thorsteinsdottir U, Gudbjartsson DF, Gretarsdottir S, Magnusson KP, Gudmundsson G, Hicks A, Jonsson T, Grant SF, Sainz J, O’brien SJ, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Levey AI, Abramson JL, Reilly MP, Vaccarino V, Wolfe ML, Gudnason V, Quyyumi AA, Topol EJ, Rader DJ, Thorgeirsson G, Gulcher JR, Hakonarson H, Kong A, Stefansson K (2005b) A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet 38(1):68–74PubMedCrossRefGoogle Scholar
  12. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U, Samani NJ, Gudmundsson G, Grant SFA, Thorgeirsson G, Sveinbjornsdottir S, Valdimarsson EM, Matthiasson SE, Johannsson H, Gudmundsdottir O, Gurney ME, Sainz J, Thorhallsdottir M, Andresdottir M, Frigge ML, Topol EJ, Kong A, Gudnason V, Hakonarson H, Gulcher JR, Stefansson K (2004) The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 36:233–239PubMedCrossRefGoogle Scholar
  13. Laird NM, Horvath S, Xu X (2000) Implementing a unified approach to family-based tests of association. Genet Epidemiol 19(Suppl 1):S36–S42PubMedCrossRefGoogle Scholar
  14. Littell RC, Milliken GA, Stroup WW, Wolfinger RD, Schabenberger O (2006) SAS for Mixed Models, 2nd edn. SAS Institute Inc., Cary, NCGoogle Scholar
  15. Lohmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G, Meitinger T, Dichgans M (2005) ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 36:731–736PubMedCrossRefGoogle Scholar
  16. Martin ER, Bass MP, Kaplan NL (2001) Correcting for a potential bias in the pedigree disequilibrium test. Am J Hum Genet 68:1065–1067PubMedCrossRefGoogle Scholar
  17. Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M (1999) KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27:29–34PubMedCrossRefGoogle Scholar
  18. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA (2002) Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425–434PubMedCrossRefGoogle Scholar
  19. Seo D, Wang T, Dressman H, Herderick EE, Iversen ES, Dong C, Vata K, Milano CA, Rigat F, Pittman J, Nevins JR, West M, Goldschmidt-Clermont PJ (2004) Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 24:1922–1927PubMedCrossRefGoogle Scholar
  20. Shah SH, Hauser ER, Crosslin D, Wang L, Haynes C, Connelly J, Nelson S, Johnson J, Gadson S, Nelson CL, Seo D, Gregory S, Kraus WE, Granger CB, Goldschmidt-Clermont P, Newby LK (2008) ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention. Atherosclerosis 201:148–154CrossRefGoogle Scholar
  21. Smith LR, Harrell FE Jr, Rankin JS, Califf RM, Pryor DB, Muhlbaier LH, Lee KL, Mark DB, Jones RH, Oldham HN (1991) Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation 84:III245–III253PubMedGoogle Scholar
  22. Spanbroek R, Grabner R, Lotzer K, Hildner M, Urbach A, Ruhling K, Moos MP, Kaiser B, Cohnert TU, Wahlers T, Zieske A, Plenz G, Robenek H, Salbach P, Kuhn H, Radmark O, Samuelsson B, Habenicht AJ (2003) Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 100:1238–1243PubMedCrossRefGoogle Scholar
  23. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102:15545–15550PubMedCrossRefGoogle Scholar
  24. Xu H, Gregory SG, Hauser ER, Stenger JE, Pericak-Vance MA, Vance JM, Zuchner S, Hauser MA (2005) SNPselector: a web tool for selecting SNPs for genetic association studies. Bioinformatics 21:4181–4186PubMedCrossRefGoogle Scholar
  25. Zhao L, Funk CD (2004) Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med 14:191–195PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • David R. Crosslin
    • 1
  • Svati H. Shah
    • 1
    • 2
  • Sarah C. Nelson
    • 1
  • Carol S. Haynes
    • 1
  • Jessica J. Connelly
    • 1
  • Shera Gadson
    • 1
  • Pascal J. Goldschmidt-Clermont
    • 3
  • Jeffery M. Vance
    • 4
  • Jason Rose
    • 1
  • Chris B. Granger
    • 2
  • David Seo
    • 3
  • Simon G. Gregory
    • 1
  • William E. Kraus
    • 2
  • Elizabeth R. Hauser
    • 1
  1. 1.Center for Human GeneticsDuke University Medical CenterDurhamUSA
  2. 2.Division of Cardiovascular MedicineDuke University Medical CenterDurhamUSA
  3. 3.Miller School of MedicineUniversity of MiamiMiamiUSA
  4. 4.Institute of Human GenomicsUniversity of MiamiMiamiUSA

Personalised recommendations